(2S,3S)-2,3-Dihydroxy-2-(1-methylethyl)butanoic Acid [(1R,7aR)-2,3,5,7a-Tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl Ester-; [1R-[1?,7(2S*,3S*),7a?]]-2,3-dihydroxy-2-(1-methylethyl)butanoic Acid (2,3,5,7a-Tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl Ester; Lycopsamine; Retronecine 9-((-)-viridiflorate);
(+)-Lycopsamine is a fully characterized chemical compound used as a reference standard of API Lycopsamine. The standard offered is compliant with regulatory guidelines. (+)-Lycopsamine is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 10285-07-01
